NCT05401110 2026-03-04
Study of Osimertinib With Carotuximab in Advanced, EGFR-mutated Non-Small Cell Lung Cancer
Cedars-Sinai Medical Center
Phase 1 Recruiting
Clinical Trials
4 trialsNCT02429843 2021-06-28
A Study of TRC105 in Combination With Paclitaxel/Carboplatin and Bevacizumab in Non-Squamous Cell Lung Cancer
University of Alabama at Birmingham
Phase 1 Completed
NCT03181308 2020-06-24
Study of Carotuximab (TRC105) Plus Nivolumab in Patients With Metastatic NSCLC
Tracon Pharmaceuticals Inc.
Phase 1 Completed
NCT03780010 2019-10-28
Study of TRC105 + Paclitaxel/Carboplatin and Bevacizumab in Patients With NSCLC
Tracon Pharmaceuticals Inc.
Phase 1 Completed